this book-our curiously ambivalent attitude to malingerers. Difficult as they are, under some circumstances we may become rather fond of them. Perhaps this is not very surprising; after all, our species has always had a soft spot for rogues. Achilles is more forthright than Odysseus, but who would you rather have to dinner? While the latter's factitious madness receives due attention here, we are left to wonder what Homer's surgeons made of the chronic pain syndrome of Philoctetes; 3 you can bet he was regarded as a problem patient. I was heartened to find a chapter devoted to the lost souls that appear in hospital emergency departments, apparently bereft of both past and future: here we have an authentic intimation that illness deception really can be a symptom of the human condition (or at least, a pervasive social malaise), and not always a coldly calculated exercise in benefit fraud.
At various places in the book much is made of the dichotomous characterization of malingerers as 'mad' or 'bad'. Clinicians might suggest an equally resonant third possibility-'sad'. Perhaps we should ask ourselves how appealing the much-discussed sick role really is. When I was a brand-new intern working the night-shift I saw a young woman whose presenting complaint was an inability to move her left hand. My meticulous and over-inclusive neurological examination disclosed no objective signs other than a chipped nail. When questioned, she admitted that the nail injury was the first thing she had noticed, and added that she thought the hand was already returning to normal. I am sure she had a very good reason to sit in casualty for three of the wee small hours with such a plainly non-organic problem. I was too callow to discover it, and I would guess that the necessary wisdom is not to be found in books. Thrombolysis revolutionized the early management of acute myocardial infarction. The treatment was designed around the established infarction pathophysiology-rupture of a coronary artery atherosclerotic plaque triggering in-situ thrombosis which results in coronary artery occlusion. Since the landmark ISIS-2 and GISSI studies there has been an explosion of randomized controlled clinical trials aimed at further reductions of hospital mortality by pharmacological manipulations of clotting and fibrinolysis. Now, however a new phase in the early management of acute infarction is being advocated-direct disruption of the occlusion by angioplasty. This is therefore a timely book. It is written by enthusiasts and each chapter stands alone and summarizes the trial evidence. But to get a balanced view you must read the whole book. When any new treatment is developed it has to show benefits over the current standard in order to replace it, and the alternatives are compared by means of randomized controlled trials (RCTs). However, replication of trial results in the real world is often disappointing. For example, thrombolysis within 1 hour of onset of symptoms of acute myocardial infarction reduces mortality by up to 50% but this benefit is quickly lost, declining to only 10% by 12 hours. This dramatic effect should have resulted in falling hospital mortality after the routine introduction of thrombolysis, but single-centre registry data (from Nottingham for example) show very little impact on hospital mortality through the 1990s. Now, in the 21st century, we are seeing a real reduction in mortality because of a nationally coordinated emphasis on reducing door-toneedle time with the introduction of new models of care including pre-hospital thrombolysis and chest-pain nurse specialists as part of the National Service Framework for Coronary Heart Disease. We have just got thrombolysis working well.
In this book Stephen Ellis advocates a change to direct angioplasty. The justification is a 2% absolute reduction in 30-day mortality shown in a recent meta-analysis of the few small RCTs that have been done. Other benefits include a halving of the stroke risk and a bigger reduction in reinfarction and recurrent ischaemia. Just as in thrombolysis, registry data from the USA, which record the actual results of primary angioplasty in practice, show much less benefit and even increased mortality. This is explained by the delays associated with this treatment approach, which requires clinical evaluation in the emergency room and then transfer to a cardiac catheterization laboratory, coronary angiography and the angioplasty. Since 'time is muscle', when the delay from arrival-to-balloon time exceeds 90 minutes the mortality benefits of primary angioplasty over thrombolysis are lost.
The effects of delays in thrombolysis have been addressed in another chapter which focuses on pre-hospital thrombolysis. Here a gain of 1 hour in the average time-tothrombolysis is associated with a reduction in mortality of about 2%. However, the absolute effect depends on when the delay occurs in the natural history of infarction. A delay of 1 hour at the start of symptoms results in a 6% absolute difference in mortality, whereas a delay of 1 hour once the infarction has become established (1-3 hours after symptoms) results in only a 1% difference and the same delay after 3-6 hours, only 0.2% absolute difference.
There are no conclusions presented in this book but the data clearly show that one size does not fit all. It appears to me that patients presenting within 3 hours of the onset of infarction should have thrombolysis. Those presenting later may benefit more by a strategy of primary angioplasty, provided that services can be organized to ensure that doorto-balloon time is no longer than 90 minutes. This will be some challenge in the UK, especially given the infrastructure costs of running such a service. The book addresses other associated questions around the use of adjuvant therapy with antiplatelet drugs and anticoagulants. The good news is that aspirin, albeit a weak platelet antagonist, gives the best therapeutic results without the disadvantage of serious bleeding complications. This is good news for the UK since aspirin is very cheap. Take, for example, single umbilical artery. A distinguished retired paediatrician telephoned me, concerned about his grandfetus which had been found through antenatal scanning to be one umbilical artery short. I scrutinized the index of the new Forfar & Arneil (F&A): try single-no; try arteryno. Try the index of the current Nelson Textbook (same publishing stable, cheaper, American)-yes, on p. 528, a concise informative paragraph. Try Google-nearly 1300 citations, reproducible instantly on my printer and no heavy book to balance on the knees. The moral? The talents of editors and contributors might be put to better use in more contemporary information transfer. In F&A the shape of things to come is indicated by a disc behind the front cover.
Kevin S Channer
So how is it for me? I have used the new F&A as a bench book for the last few months and it works, up to a point. Most conditions encountered in general paediatric consulting practice have been covered and the contributions are up to date and well referenced. Highlights are adolescent medicine, respiratory disorders (although try using this book to sort out chronic cough as a symptom) and, a personal bias, nephrology. Quibbles? One is constipation. I was reminded recently-embarrassingly, by the child's father-that constipation may be a presenting feature (not presenting factor; this wayward index again) of coeliac disease; and cow's milk intolerance and constipation may be linked in the absence of atopy. Enuresis is discussed more informatively under nephrology than under psychiatry, from which it should have been blue pencilled. My main beef, however, is with this book's two-dimensional context of child life and health-a weakness common to most textbooks. The three principal elements to clinical paediatric practice are diagnosis, treatment and population medicine, all within a whole child/family framework. Though management of defined conditions and the public health of paediatrics are dealt with soundly, the real challenge to the personal physician is unravelling the cause of symptoms and relieving those which defy diagnostic classification, including the whole fascinating (and evidencelimited) spectrum of functional illness, and those which do not remit when the disease thought to cause them is treated 'successfully'. The excellent short chapter on pain management makes a good start in this respect: now for breathlessness, dizziness-and fatigue.
I thank the families of McIntosh, Helms and Smyth for loaning them to this project and salute them on the result. The style and content are even and they have largely succeeded in avoiding overlap. Do not baulk at its cost: at just over £1 per contributor you are getting a bargain (and a largely British one, despite the American spelling). This 6th edition was born (4.5 kg) just 5 years after the 5th, and the life expectancy of its knowledge base may prove even shorter. In what form the 7th will be presented I leave you, dear reader, to guess.
Timothy Lachlan Chambers
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